CVS Group plc Placing Update (1632F)

TIDMCVSG

RNS Number : 1632F

CVS Group plc

16 February 2018

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF IRELAND OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT ITSELF CONSTITUTE AN OFFER FOR SALE OR SUBSCRIPTION OF ANY SECURITIES IN THE COMPANY. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES OF CVS GROUP PLC IN ANY JURISDICTION IN WHICH ANY SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION, SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH ANY INVESTMENT DECISION IN RESPECT OF CVS GROUP PLC.

CAPITALISED TERMS IN THIS ANNOUNCEMENT SHALL HAVE THE SAME MEANING AS IN THE ANNOUNCEMENT HEADED "PROPOSED ACCELERATED BOOKBUILD" ISSUED EARLIER TODAY.

16 February 2018

This announcement contains inside information

CVS Group plc

(the "Company")

Placing Update

CVS Group plc (AIM: CVSG), one of the UK's leading providers of integrated veterinary services, announces that, further to the announcements made earlier today, the Company has successfully raised approximately GBP60 million (before expenses) by way of an accelerated bookbuild. The Placing was heavily oversubscribed and has received strong support from both existing and new investors.

In connection with the Placing, the Company will issue 5,581,395 new Ordinary Shares (the "Placing Shares") at a price of 1075 pence each (the "Placing Price").

The issue of the Placing Shares is being made under existing authorities and remains subject to Admission, which is expected at 08:00 on Tuesday 20 February.

Participants in the Placing will be contacted by N+1 Singer shortly to confirm their final allocations and a further announcement will be made in due course.

For further information please contact:

 
 CVS Group plc 
 Simon Innes, Chief Executive      Tel: [phone] 
 Nick Perrin, Finance Director 
 
 N+1 Singer (Nominated Adviser 
  and Broker) 
 Aubrey Powell                     Tel: [phone] 
  Michael Taylor 
  Liz Yong 
  James Hopton 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

IOEFMGMZZVRGRZM

(END) Dow Jones Newswires

February 16, 2018 07:45 ET (12:45 GMT)